Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terpene-enriched versus non-enriched medical cannabis oil for chronic pain
MOH_2021-09-01_010236Phase 2Not yet recruiting
- Sponsor
- פרופ' אליעד דוידסון
- Start
- Jul 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of terpene-enriched medical cannabis oil and cannabis oil in chronic pain (2 arms), sponsored by פרופ' אליעד דוידסון. Primary endpoints: Change in standardized questionnaire score for pain relief and Change in pain-related functional capacity. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
terpene-enriched medical cannabis oilcannabis oil
03
Conditions
chronic pain
Beyond the preview
Go deeper on MOH_2021-09-01_010236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-09-01_010236.